# Fibrinogen Early In Severe Trauma StudY II

> **NCT05449834** · PHASE3 · RECRUITING · sponsor: **Australian and New Zealand Intensive Care Research Centre** · enrollment: 900 (estimated)

## Conditions studied

- Trauma
- Haemorrhagic Shock
- Coagulopathy

## Interventions

- **DRUG:** Fibrinogen Concentrate
- **OTHER:** Cryoprecipitate

## Key facts

- **NCT ID:** NCT05449834
- **Lead sponsor:** Australian and New Zealand Intensive Care Research Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-11-21
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 900 (ESTIMATED)
- **Last updated:** 2026-02-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05449834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05449834, "Fibrinogen Early In Severe Trauma StudY II". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05449834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*